Multiple primary malignancies involving primary sporadic colorectal cancer in Japan: incidence of gastric cancer with colorectal cancer patients may be higher than previously recognized

World Journal of Surgical Oncology

Toshiki Rikiyama²  Fumio Konishi¹  Hisanaga Horie²  Hiroshi Noda²  Yutaka J Kawamura³  Shingo Tsujinaka²  Junichi Sasaki²  Yuta Muto²  Koichi Suzuki²  Takaharu Kato² 

[1] Nerima Hikarigaoka Hospital, 2-11-1 Hikarigaoka, Nerima-ku 179-0072, Tokyo, Japan;Department of Surgery, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku 330-8503, Saitama, Japan;Tsudanuma Central General Hospital, 1-9-17 Yatsu, Narashino-shi 275-0026, Chiba, Japan

关键词: Multiple primary malignancies;    Gastric cancer;    Colorectal cancer;   

Others  :  1146416
DOI  :  10.1186/s12957-014-0432-2

 received in 2014-11-03, accepted in 2014-12-24,  发布年份 2015

【 摘 要 】

Background

Improvement in the prognosis of colorectal cancer (CRC) patients has led to increasing occurrences of multiple primary malignancies (MPMs) alongside CRC but little is known about their characteristics. This study was undertaken to clarify the clinical and pathological features of MPMs, especially those at extra colonic sites, in patients with CRC.

Methods

We reviewed 1,111 patients who underwent operations for primary sporadic CRC in Saitama Medical Center, Jichi Medical University between April 2007 and March 2012. Two patients with familial adenomatous polyposis, one with hereditary non-polyposis colorectal cancer, two with colitic cancer, and any patients with metastasis from CRC were excluded. We compared the clinicopathological features of CRC patients with and without MPMs.

As a control, we used a database compiled of patients with gastric cancer (GC) detected by mass screening performed in the Saitama Prefecture in Japan 2010 and compared these with CRC patients with synchronous GC.

Results

Multiple primary malignancies at extracolonic sites were identified in 117 of 1,111 CRC patients (10.5%). The median age was 68 (range, 29 to 96) versus 71 (50 to 92) (P < 0.001). The incidence of GC (44.4% (52 of 117)) was the highest of all MPMs. All CRC patients with GC were older than 57 years. Synchronous GC was detected in 26 patients.

By contrast, out of 200,007 screened people, 225 people were diagnosed as having GC in the Saitama Prefecture. The age-standardized incidence of synchronous GC in CRC patients was significantly higher (0.53%) than in the control group (0.03%) (odds ratio, 18.8; 95% confidence interval, 18.6 to 19.0; P < 0.001).

Conclusion

Patients with CRC who were older than 50 years preferentially developed GC synchronously and metachronously. Thus, this patient group should undergo careful perioperative screening for GC.

【 授权许可】

   
2015 Kato et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90.
• [2]Yiu HY, Whittemore AS, Shibata A. Increasing colorectal cancer incidence rates in Japan. Int J Cancer. 2004; 109:777-81.
• [3]Yee YK, Tan VP, Chan P, Hung IF, Pang R, Wong BC. Epidemiology of colorectal cancer in Asia. J Gastroenterol Hepatol. 2009; 24:1810-6.
• [4]Lu JB, Sun XB, Dai DX, Zhu SK, Chang QL, Liu SZ et al.. Epidemiology of gastroenterologic cancer in Henan Province. China World J Gastroenterol. 2003; 9:2400-3.
• [5]Yang L, Parkin DM, Li LD, Chen YD, Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991–2005. Br J Cancer. 2004; 90:2157-66.
• [6]Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005; 6:871-6.
• [7]Kobayashi Y, Arimoto H, Watanabe S. Occurrence of multiple primary cancer at the National Cancer Center Hospital, 1962–1989. Jpn J Clin Oncol. 1991; 21:233-51.
• [8]Tsukuma H, Fujimoto I, Hanai A, Hiyama T, Kitagawa T, Kinoshita N. Incidence of second primary cancers in Osaka residents, Japan, with special reference to cumulative and relative risks. Jpn J Cancer Res. 1994; 85:339-45.
• [9]Lee WS, Lee JN, Choi S, Jung M, Baek JH, Lee WK. Multiple primary malignancies involving colorectal cancer–clinical characteristics and prognosis with reference to surveillance. Langenbecks Arch Surg. 2010; 395:359-64.
• [10]Lee SH, Ahn BK, Baek SU. Multiple primary cancers in extracolonic sites with colorectal cancer. Int J Color Dis. 2009; 24:301-4.
• [11]Oya M, Takahashi S, Okuyama T, Yamaguchi M, Ueda Y. Synchronous colorectal carcinoma: clinico-pathological features and prognosis. Jpn J Clin Oncol. 2003; 33:38-43.
• [12]Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D et al.. AJCC Cancer Staging Manual. 6th ed. Springer, New York; 2002.
• [13]Matsuda A, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H. Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2013; 43:328-36.
• [14]Hisamichi S. Screening for gastric cancer. World J Surg. 1989; 13:31-7.
• [15]Maruyama H, Hasuike Y, Furukawa J, Naoi M, Takata N, Yayoi E et al.. Multiple colorectal carcinomas and colorectal carcinoma associated with extracolonic malignancies. Surg Today. 1992; 22:99-104.
• [16]Ueno M, Muto T, Oya M, Ota H, Azekura K, Yamaguchi T. Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer. Int J Clin Oncol. 2003; 8:162-7.
• [17]Yamamoto S, Yoshimura K, Ri S, Fujita S, Akasu T, Moriya Y. The risk of multiple primary malignancies with colorectal carcinoma. Dis Colon Rectum. 2006; 49:S30-6.
• [18]Lim SB, Jeong SY, Choi HS, Sohn DK, Hong CW, Jung KH et al.. Synchronous gastric cancer in primary sporadic colorectal cancer patients in Korea. Int J Color Dis. 2008; 23:61-5.
• [19]Yun HR, Yi LJ, Cho YK, Park JH, Cho YB, Yun SH et al.. Double primary malignancy in colorectal cancer patients - MSI is the useful marker for predicting double primary tumors. Int J Color Dis. 2009; 24:369-75.
• [20]Yoon SN, Oh ST, Lim SB, Kim TW, Kim JH, Yu CS et al.. Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer. World J Surg. 2010; 34:2168-76.
• [21]Mizoue T, Yoshimura T, Tokui N, Hoshiyama Y, Yatsuya H, Sakata K et al.. Prospective study of screening for stomach cancer in Japan. Int J Cancer. 2003; 106:103-7.
• [22]Schatzkin A, Baranovsky A, Kessler LG. Diet and cancer. Evidence from associations of multiple primary cancers in the SEER program. Cancer. 1988; 62:1451-7.
• [23]Ha TK, An JY, Youn HG, Noh JH, Sohn TS, Kim S. Surgical outcome of synchronous second primary cancer in patients with gastric cancer. Yonsei Med J. 2007; 48:981-7.
• [24]Eom BW, Lee HJ, Yoo MW, Cho JJ, Kim WH, Yang HK et al.. Synchronous and metachronous cancers in patients with gastric cancer. J Surg Oncol. 2008; 98:106-10.
• [25]Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer. 1993; 54:759-64.
• [26]Sawai T, Nanashima A, Tsuji T, Yamaguchi H, Yasutake T, Nakagoe T et al.. Instability of chromosome 17 and the p53 locus in non-familial colorectal cancer with multiple primary malignancies. J Exp Clin Cancer Res. 2001; 20:401-5.
• [27]Wynder EL, Mushinski MH, Spivak JC. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer. 1977; 40:1872-8.
• [28]Saito S, Hosoya Y, Togashi K, Kurashina K, Haruta H, Hyodo M et al.. Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer. Surg Today. 2008; 38:20-5.
• [29]Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P et al.. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005; 352:1851-60.
• [30]Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J et al.. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 2009; 137:1621-7.
• [31]Vasen HF, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L et al.. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008; 57:704-13.
• [32]Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T et al.. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992; 102:760-6.
• [33]An international association between Helicobacter pylori infection and gastric cancer. Lancet. 1993; 341:1359-62.
• [34]Graham DY, Adam E, Klein PD, Evans DJ, Evans DG, Hazell SL et al.. Epidemiology of Campylobacter pylori infection. Gastroenterol Clin Biol. 1989; 13:84B-8.
• [35]Evans HS, Moller H, Robinson D, Lewis CM, Bell CM, Hodgson SV. The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut. 2002; 50:647-52.
• [36]Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A et al.. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008; 57:298-305.